Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Todos Medical Ltd (OP: TOMDF ) 0.0001 UNCHANGED Last Price Updated: 11:20 AM EDT, Sep 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Todos Medical Ltd < Previous 1 2 Next > CapitalGainsReport: Today’s OTC Bounce Watchlist (TOMDF, PHIL, RGBP, AIAD) February 08, 2023 CapitalGainsReport: Today’s OTC Bounce Watchlist (TOMDF, PHIL, RGBP, AIAD) Via News Direct Exposures COVID-19 Most Active On The OTC Markets In September – A Look Back As October Comes To A Close October 27, 2022 The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) declined by 9.62% in September – its largest decline in 2022. Via Benzinga A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know September 12, 2022 While July gave markets around the world a breather, August reestablished 2022’s choppy financial conditions. Via Benzinga Todos Medical To Present At The Emerging Growth Conference April 25, 2022 - Wednesday, April 27, 2022 at 10:00am – 10:45am EST - Via Benzinga Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics April 21, 2022 Strengthens Management Team and Positions the Company for Growth and Expansion Via Benzinga Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group April 20, 2022 New York, NY, and Tel Aviv, ISRAEL – April 19, 2022 - Todos Medical, Ltd. Via Benzinga Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases August 11, 2022 Gerald Commisiong, CEO of Todos Medical Ltd. (OTCQB: TOMDF), was a guest speaker at Benzinga’s All Access on August 5th, 2022. Todos Medical is a leading in vitro diagnostics company developing of... Via Benzinga Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim May 02, 2022 5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing) low 3CL protease levels Via Benzinga Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022 April 27, 2022 New York, NY, and Tel Aviv, ISRAEL – April 27, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study April 20, 2022 New York, NY, and Tel Aviv, ISRAEL – April 20, 2022 - Todos Medical, Ltd. Via Benzinga New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid April 12, 2022 Photo credit: Todos Medical This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 04, 2022 New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 01, 2022 New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Reports Case Study Of Patient With Long COVID March 31, 2022 New York, NY, and Tel Aviv, ISRAEL, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. Via Benzinga Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products March 28, 2022 New York, NY, and Tel Aviv, ISRAEL – March 27, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label April 06, 2022 New York, NY, and Tel Aviv, ISRAEL – April 6, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned... Via Benzinga Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants April 04, 2022 New York, NY, and Tel Aviv, ISRAEL – April 4, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical To Present At The Proactive One2One Virtual Forum March 17, 2022 - Thursday, March 17, 2022 at 2:00PM – 2:30PM ET - Via Benzinga Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma March 16, 2022 - Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - Via Benzinga Todos Medical To Present At The Emerging Growth Conference March 15, 2022 - Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST - Via Benzinga Todos Medical Appoints Greg Meiselbach As Vice President Of Government Affairs March 08, 2022 New York, NY, and Tel Aviv, ISRAEL – March 8, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today... Via Benzinga These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators February 14, 2022 Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Benzinga Announces This Week's All Access Guests February 10, 2022 Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 11 at 9:15 am ET. The Lineup 9:15 am... Via Benzinga Abbott Labs Outlook Cools the Omicron Led Testing Boom January 28, 2022 Photo by Adam Nieścioruk on Unsplash Via Benzinga Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-19 Patients January 27, 2022 Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy Via Benzinga Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients January 24, 2022 Clinical Data will be released Thursday, January 27th, 2022 New York, NY, and Tel Aviv, ISRAEL – January 24, 2021 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive... Via Benzinga PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID® January 19, 2022 In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA January 19, 2022: Working along with the NFL Host Committee, Celebrity... Via Benzinga Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies January 18, 2022 New York, NY, and Tel Aviv, ISRAEL – January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released... Via Benzinga Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022 January 12, 2022 CEO Fox Business Interview discussing COVID testing and solutions to address the crisis now online at https://video.foxbusiness.com/v/6291325085001#sp=show-clips New York... Via Benzinga Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022 January 11, 2022 “COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL – January 10, 2022 - Todos Medical,... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.